Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG O-16:0_18:1_22:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST003678 AN006039 The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST003326 AN005449 Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism Liver Mouse Liver disease University of Melbourne LC-MS
ST003248 AN005320 Effects of acute mitoregulin loss on cardiac mitochondrial lipids in mice Mitochondria Mouse Cardiovascular disease University of Iowa LC-MS
ST003038 AN004984 Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. Liver Mouse Diabetes Vanderbilt University Medical Center LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002283 AN003730 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
ST001989 AN003241 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) LNCaP cells Human Cancer IGMM LC-MS
  logo